Telemedicine and Gestational Diabetes Mellitus: Systematic Review and Meta-Analysis

Cureus. 2024 Oct 20;16(10):e71907. doi: 10.7759/cureus.71907. eCollection 2024 Oct.

ABSTRACT

Hyperglycemia known as gestational diabetes mellitus (GDM) can happen during pregnancy and poses a risk to the developing baby as well as the mother. Glycemic control, patient involvement, and diabetes management might all be improved via telemedicine (TM). Therefore, this study aimed to compare TM versus standard care for GDM in terms of maternal and fetal outcomes. The authors searched for randomized controlled trials (RCTs) contrasting TM with conventional care among gestational diabetes women across various databases including PubMed, the Cochrane Central Register of Controlled Studies, and Google Scholar from April 2010 to December 2023. This meta-analysis included a total of 2,192 pregnant women from 12 RCT studies and was analyzed by RevMan (version 5.4; Cochrane, London). Applying fixed and random effects was based on heterogeneity. There was a statistically significant difference in the effect on the control of blood glucose levels two-hour postprandial (MD = -0.45, 95%CI = (-0.84, -0.06), P = 0.02) and on the cesarean section effect (RR = 0.74, 95%CI = (0.63, 0.87), P < 0.001) when TM was compared to standard care for GDM. However, there was no statistically significant difference in the effect on other maternal or fetal outcomes such as HBA1c, fasting blood glucose, preterm birth, fetal macrosomia, or hypoglycemia. TM interventions are more successful than standard therapy in lowering the rate of cesarean section and decreasing the two-hour postprandial glucose level of GDM patients, which is essential for improving glycemic control and reducing cardiovascular disease.

PMID:39564055 | PMC:PMC11574696 | DOI:10.7759/cureus.71907